Celia Lin
2022
In 2022, Celia Lin earned a total compensation of $1.6M as Chief Medical Officer at Vera Therapeutics, a 10% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $176,840 |
|---|---|
| Option Awards | $733,123 |
| Salary | $440,487 |
| Stock Awards | $232,500 |
| Total | $1,582,950 |
Lin received $733.1K in option awards, accounting for 46% of the total pay in 2022.
Lin also received $176.8K in non-equity incentive plan, $440.5K in salary and $232.5K in stock awards.
Rankings
In 2022, Celia Lin's compensation ranked 2,121st out of 5,625 executives tracked by ExecPay. In other words, Lin earned more than 62.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,121 out of 5,625 | 62nd |
Division Manufacturing | 1,138 out of 3,053 | 63rd |
Major group Chemicals And Allied Products | 488 out of 1,380 | 65th |
Industry group Drugs | 448 out of 1,281 | 65th |
Industry Pharmaceutical Preparations | 323 out of 927 | 65th |
Source: SEC filing on March 30, 2023.
Lin's colleagues
We found two more compensation records of executives who worked with Celia Lin at Vera Therapeutics in 2022.